Company: ATHE
Filing Date: 2025-08-29
Form Type: 20-F
Source: 0001213900-25-082027
Chunk: 147

Company: ALTERITY THERAPEUTICS LTD
Filing Date: 2025-08-29
Form: 20-F
Item: Item 18
Chunk 147
---
 under options exercised                       6,333,333       0.004           48,873    
February 3,2025          Issue of shares under ATM Facility                          164,242,200      0.0129        2,122,173    
February 17,2025         Issue of Placement shares                                 1,165,841,830      0.0110       12,824,260    
March 14, 2025           Issue of shares under options exercised             161                      0.0100                2    
April 4, 2025            Issue of Placement shares                                 2,470,521,806      0.0110       27,175,740    
June 30, 2025            Security issuance costs                                               -                   (2,774,168   )
Year end June 30, 2025                                                             3,882,255,368                   39,796,477    
F-26

ALTERITY THERAPEUTICS LIMITED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – in Australian dollars (unless otherwise noted)

10. ISSUED CAPITAL (continued)

(c) Terms and Conditions of Issued Capital
   Ordinary shares
   Ordinary shares have the right to receive dividends as declared and, in the event of a winding up of the Group, to participate in the proceeds from the sale of all surplus assets in proportion to the number of and amounts paid up on shares held. Ordinary shares entitle their holder to vote, either in person or by proxy, at a meeting of the Group’s shareholders.   Options
   Option holders do not have the right to receive dividends and are not entitled to vote at a meeting of the Group’s shareholders. Options may be exercised at any time from the date they vest to the date of their expiration. Share options convert into ordinary shares on a one for one basis on the date they are exercised.   (d) Shares Issued after Reporting Date
 
No shares have been issued after the reporting date.

11. RESERVES
 

                                                                                                                                         Years Ended June 30,                        
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                Notes        2025                      2024                       2023               
(a) Share Based Payments                                                                                                                                                             
2,683,471,567 (2024: 3,250,009,092, 2023: 170,042,720) options for fully paid ordinary shares        11(c)            5,342,304                  4,